NCT00349245View on ClinicalTrials.gov

Dexmedetomidine vs. Remifentanil for Sedation During AFI

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Intubation, Endotracheal
Interventions
DRUG

Remifentanil

DRUG

Dexmedetomidine

Trial Locations (1)

77030

Memorial Hermann Hospital, Houston

All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER

NCT00349245 - Dexmedetomidine vs. Remifentanil for Sedation During AFI | Biotech Hunter | Biotech Hunter